Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/04/2010EP2213292A1 Double-stranded oligonucleotides
08/04/2010EP2213291A1 Antisense inhibition of PTP1B expression
08/04/2010EP2213290A1 Agent for improving motor complications or psychiatric symptoms in parkinson's disease
08/04/2010EP2213289A1 Combination treatment for diabetes mellitus
08/04/2010EP2213288A1 NAMPT and vitamin B3 for treating or preventing diseases
08/04/2010EP2213287A1 Inhibition of biofilm formation
08/04/2010EP2213286A1 N-(phenyl or pyridyl)prenylamine derivatives for the treatment of obesity, diabetes and cardiovascular diseases
08/04/2010EP2213285A2 Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases
08/04/2010EP2213284A1 Preparation for application to body surface and preparation holding sheet for application to body surface
08/04/2010EP2213282A1 Pharmaceutical forms for the release of active compounds
08/04/2010EP2213281A1 Pharmaceutical composition comprising N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride
08/04/2010EP2213280A1 Formulations comprising glucosinolate and myrosinase
08/04/2010EP2212420A2 Use of oligonucleotides with modified bases as antiviral agents
08/04/2010EP2212333A1 Thienopyrimidine and pyrazolopyrimidine compounds and their use as mtor kinase and pi3 kinase inhibitors
08/04/2010EP2212332A1 Substituted tricyclic compounds and methods of use thereof
08/04/2010EP2212330A2 Novel compounds of reverse turn mimetics and the use thereof (3)
08/04/2010EP2212329A2 Novel compounds of reverse turn mimetics and the use thereof (1)
08/04/2010EP2212328A2 Novel compounds of reverse turn mimetics and the use thereof (2)
08/04/2010EP2212327A1 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1
08/04/2010EP2212326A1 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
08/04/2010EP2212325A2 2-arylmethylazetidine-carbapenem-3-carboxylic acid ester derivative or its salt, process for the preparation thereof and pharmaceutical composition comprising the same
08/04/2010EP2212324A1 Compounds having antiviral properties
08/04/2010EP2212323A2 Imidazo [1,2-a] pyridine derivatives useful as alk inhibitors
08/04/2010EP2212322A1 Quinolizidinone m1 receptor positive allosteric modulators
08/04/2010EP2212321A2 (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease
08/04/2010EP2212318A1 Thiazole derivatives as protein kinase inhibitors
08/04/2010EP2212317A1 4,4-disubstituted piperidines
08/04/2010EP2212316A1 Amino 1,2,4-triazole derivatives as modulators of mglur5
08/04/2010EP2212315A1 Trisubstituted piperidines
08/04/2010EP2212314A1 Imidazolidine-2,4-dione (hydantoin) derivatives useful as npy y2 receptor modulators
08/04/2010EP2212312A2 5-lipoxygenase activating protein (flap) inhibitor
08/04/2010EP2212311A2 Maleate salts of (e)-n-{4-ý3-chloro-4-(2-pyridinylmethoxy)anilino¨-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
08/04/2010EP2212309A1 Trisubstituted 1,2,4-triazoles
08/04/2010EP2212305A1 Beta-lactone compounds
08/04/2010EP2212303A1 Novel benzamide derivatives useful as potassium channel modulators
08/04/2010EP2212301A1 An improved process for preparation of letrozole and its intermediates
08/04/2010EP2212300A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators
08/04/2010EP2212299A1 Piperazinyl-sulfonamide derivatives useful in the treatment of gpr38 receptor mediated diseases
08/04/2010EP2212298A1 Deuterated etravirine
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP2212292A1 Amides useful as inhibitors of voltage-gated sodium channels
08/04/2010EP2212291A1 Heterocycle phenyl amide t-type calcium channel antagonists
08/04/2010EP2212290A1 Aryl amides useful as inhibitors of voltage-gated sodium channels
08/04/2010EP2212287A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
08/04/2010EP2212285A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
08/04/2010EP2212284A2 Calcium receptor modulating agents
08/04/2010EP2212283A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
08/04/2010EP2212282A1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
08/04/2010EP2212280A1 Amide linked modulators of y-secretase
08/04/2010EP2212277A1 Amine linked modulators of y-secretase
08/04/2010EP2212276A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor
08/04/2010EP2211897A1 Altered n-cadherin processing in tumor cells by furin and proprotein convertase 5a (pc5a)
08/04/2010EP2211883A1 Antibacterial composition comprising salvia extracts
08/04/2010EP2211882A2 Method for preparing stable hop powder
08/04/2010EP2211880A1 Treatment regime for proliferative disorders
08/04/2010EP2211872A1 Hyperbranched polyglycerol for improving heart function
08/04/2010EP2211871A1 Method for inhibiting angiogenesis or for treatment of cancer
08/04/2010EP2211870A1 Cytidine analogs for treatment of myelodysplastic syndromes
08/04/2010EP2211869A2 Idarubicin for the treatment of lymphoma in a dog
08/04/2010EP2211868A2 Silicate containing compositions and methods of treatment
08/04/2010EP2211867A1 Process for synthesizing phosphonic and phosphinic acid compounds
08/04/2010EP2211865A2 Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases
08/04/2010EP2211864A1 Pyrazinyl amide t-type calcium channel antagonists
08/04/2010EP2211863A1 Combination therapy
08/04/2010EP2211862A2 Csf-1r inhibitors for treatment of cancer and bone diseases
08/04/2010EP2211861A1 Clioquinol for the treatment of hematological malignancies
08/04/2010EP2211860A1 Combination therapy for reducing side effects using cannabinoid receptor ligands
08/04/2010EP2211858A2 Use of quaternary pyridinium salts for inhibiting cancer metastases
08/04/2010EP2211857A1 Use of quaternary pyridinium salts for radioprotection
08/04/2010EP2211855A1 Thrombopoietin receptor agonist (tpora) kills acute human myeloid leukemia cells
08/04/2010EP2211854A1 Methods and compositions for the treatment of cancer using benzopyrone-type parp inhibitors
08/04/2010EP2211853A2 A cancer sensitizer comprising chlorogenic acid
08/04/2010EP2211851A2 Laminins, derivatives, and compositions including same and method for their therapeutic use
08/04/2010EP2211850A1 A system and method to improve sensory function
08/04/2010EP2211848A1 Trans-clomiphene for metabolic syndrome
08/04/2010EP2211847A1 Controlled-release pharmaceutical formulation
08/04/2010EP2211845A2 Glucocorticoid receptor antagonists such as mifepristone for treating cushing's syndrome
08/04/2010EP2211839A1 Long acting injectable formulations
08/04/2010EP2211837A2 A non-aqueous topical solution of diclofenac and process for preparing the same
08/04/2010EP2211836A2 Taste-masked orally disintegrating tablets of memantine hydrochloride
08/04/2010EP2211835A1 Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
08/04/2010EP2211760A1 Polymeric drug delivery systems and thermoplastic extrusion processes for producing such systems
08/04/2010EP2211639A2 Novel nacl salt substitute, use thereof and products containing same
08/04/2010EP2211620A1 Therapeutic compounds
08/04/2010EP2211618A1 Piperidinylhydroxyethylpiperidines as modulators of chemokine receptors
08/04/2010EP2211615A1 Pyridosulfonamide derivatives as pi3 kinase inhibitors
08/04/2010EP2062598B1 Gel type enteric nutrient
08/04/2010EP2029540B1 Benzamide derivatives and uses related thereto
08/04/2010EP2015759B1 Combination therapy
08/04/2010EP2010506B1 Diazepan derivatives modulators of chemokine receptors
08/04/2010EP1999128B1 Tetomilast polymorphs
08/04/2010EP1971330B1 Combination of triazine derivatives and insulin sensitisers
08/04/2010EP1951243B1 Treatment of solid tumor diseases with combinations comprising imatinib and an efflux pump inhibitor
08/04/2010EP1874737B1 Substituted 2-aminoalkylthio-benzimidazoles and use thereof for reducing blood sugar levels
08/04/2010EP1831201B1 Piperidine and azetidine derivatives as glyt1 inhibitors
08/04/2010EP1819362B1 Topical nepafenac formulations
08/04/2010EP1750702B1 Method of bowel cleansing
08/04/2010EP1747200B1 Alkaloid compounds and their use as anti-malarial drugs
08/04/2010EP1709021B1 Selective estrogen receptor modulators for the treatment of vasomotor symptoms
08/04/2010EP1682154B1 Process for preparing phytosterol dispersions for application in beverages
1 ... 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 ... 7860